Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz® with the RhodoLED® lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne.
Fundz sees it the moment Biofrontera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WoburnBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical